NuCana (NCNA) Current Assets (2016 - 2025)
NuCana's (NCNA) quarterly Current Assets came in at $35.7 million in Q4 2025, up 126.97% year-on-year from $15.7 million in Q4 2024, and down 11.26% quarter-over-quarter from $40.3 million in Q3 2025.
NuCana (NCNA) Current Assets (2016 - 2025) Analysis & Trends
NuCana has disclosed Current Assets across 10 years of filings, most recently posting $35.7 million for Q4 2025.
- Current Assets for Q4 2025 came in at $35.7 million, up 126.97% year-over-year; the trailing twelve-month figure through Dec 2025 was $35.7 million (up 126.97% YoY), and the FY2025 annual result was $35.4 million, up 125.9% from the prior year.
- Current Assets came in at $35.7 million for Q4 2025 at NuCana, down from $40.3 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $131.0 million in Q1 2021 to a low of $11.5 million in Q1 2025.
- The 5-year median for Current Assets is $43.8 million (2023), against an average of $56.4 million.
- Peak annual rise in Current Assets reached 126.97% in 2025, while the deepest fall reached 58.95% in 2025.
- NuCana's Current Assets stood at $96.5 million in 2021, then sank by 33.27% to $64.4 million in 2022, then plunged by 51.79% to $31.1 million in 2023, then tumbled by 49.3% to $15.7 million in 2024, then soared by 126.97% to $35.7 million in 2025.
- The last three Current Assets figures came in at $35.7 million (Q4 2025), $40.3 million (Q3 2025), and $18.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 3.59 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 600.85 Mn |
| 10 | NuCana | 29.13 Bn | 29.13 Bn | - | 35.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 35.73 Mn |
| Sep 30, 2025 | 40.26 Mn |
| Jun 30, 2025 | 18.32 Mn |
| Mar 31, 2025 | 11.48 Mn |
| Dec 31, 2024 | 15.74 Mn |
| Sep 30, 2024 | 21.93 Mn |
| Jun 30, 2024 | 21.89 Mn |
| Mar 31, 2024 | 27.97 Mn |
| Dec 31, 2023 | 31.05 Mn |
| Sep 30, 2023 | 38.82 Mn |
| Jun 30, 2023 | 47.41 Mn |
| Mar 31, 2023 | 55.16 Mn |
| Dec 31, 2022 | 64.42 Mn |
| Sep 30, 2022 | 73.57 Mn |
| Jun 30, 2022 | 76.65 Mn |
| Mar 31, 2022 | 87.98 Mn |
| Dec 31, 2021 | 96.54 Mn |
| Sep 30, 2021 | 112.08 Mn |
| Jun 30, 2021 | 120.81 Mn |
| Mar 31, 2021 | 130.95 Mn |